Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001437749-22-018624
Filing Date
2022-08-03
Accepted
2022-08-03 16:53:44
Documents
3
Period of Report
2022-08-03

Document Format Files

Seq Description Document Type Size
1 FORM PRE 14A acrx20220802_pre14a.htm PRE 14A 251712
2 card1.jpg GRAPHIC 123269
3 card2.jpg GRAPHIC 117634
  Complete submission text file 0001437749-22-018624.txt   584393
Mailing Address 25821 INDUSTRIAL BOULEVARD SUITE 400 HAYWARD CA 94545
Business Address 25821 INDUSTRIAL BOULEVARD SUITE 400 HAYWARD CA 94545 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-35068 | Film No.: 221133405
SIC: 2834 Pharmaceutical Preparations